Clinical Trials
2 trialsNCT01021748 2018-08-07
A Combination Therapy Study of MK-2206 and AZD6244 in Participants With Advanced Solid Tumors (MK-2206-010)
Merck Sharp & Dohme LLC
Phase 1 Completed
NCT01071018 2015-09-07
A Study of MK2206 in Locally Advanced or Metastatic Solid Tumors (2206-007)
Merck Sharp & Dohme LLC
Phase 1 Completed